The GLP Report

Head-to-head

Hims & Hers vs Zealthy (2026)

Pricing, medications, clinical support, and our verdict on which fits which reader.

Last verified:

TL;DR verdict

Better for lowest 12-month cost

Zealthy

Better for clinical support

Hims & Hers

Quick compare

Side-by-side comparison of Hims & Hers, Zealthy
CriterionHims & HersZealthy
Starting price (month 1)$199/mo$135/mo
Maintenance monthly price$249/mo$249/mo
12-month true total$2,938$2,874
Medications offeredCompounded Semaglutide (injection), Brand-name Wegovy (via Novo Nordisk partnership), Oral GLP-1 blendCompounded Semaglutide, Brand-name Wegovy (via prior-auth navigation), Brand-name Zepbound (via prior-auth navigation)
FDA-approved options availableYesYes
Compounded options availableYesYes
Consultation formatAsynchronousAsynchronous
States servedAll 50 statesAll 50 states
Coaching includedAvailable as add-onNot offered
Cancellation policyMonthly, no long-term contract; cancel any time via the appMonthly; cancel in member portal
Prescription turnaround (SLA)See provider reviewSee provider review
Lab work requiredSee provider reviewSee provider review
Customer support hoursSee provider reviewSee provider review
Trustpilot score4.3 / 5 (28,500 reviews)4.0 / 5 (2,400 reviews)
FDA warning letter historyReceived 2025-09-12 · resolvedNone

Choose Hims & Hers if…

  • Readers who want brand recognition and a polished app experience
  • Readers looking for FDA-approved Wegovy via the Novo Nordisk partnership
  • Members who value mobile-first refills and quick re-consults
Read full Hims & Hers review →

Choose Zealthy if…

  • Readers who might qualify for insurance coverage of Wegovy or Zepbound
  • Readers willing to invest effort in prior-auth for brand-name access
  • Members who want both compounded and FDA-approved paths under one roof
Read full Zealthy review →

Regulatory & risk snapshot

Regulatory & risk snapshot

FDA warning letter: Received 2025-09-12; resolved.September 2025 letter cited marketing claims on compounded semaglutide messaging. Hims & Hers revised advertising language in Q4 2025; FDA acknowledged resolution. Surface this history in the Regulatory & Risk Snapshot section of the provider review.

Class action status: None active on record.

Regulatory & risk snapshot

FDA warning letters: None on record as of our most recent verification.

Class action status: None active on record.

Common side effects

GLP-1 medications carry a recognized side-effect profile. Reported effects include:

  • Gastrointestinal (GI) symptoms — nausea, vomiting, diarrhea, constipation; most common during titration.
  • Pancreatitis risk — discontinue and seek care if you develop persistent severe abdominal pain.
  • Thyroid concerns — these medications carry a boxed warning for thyroid C-cell tumors observed in rodents.
  • Other reported effects — gallbladder disease, kidney injury (often dehydration-mediated), injection-site reactions, and hypoglycemia (especially with insulin or sulfonylurea use).

This list is not exhaustive. Individual results vary; clinical-trial outcomes may not reflect typical user experience. Discuss your full medical history with a qualified healthcare professional before starting treatment.

Who should not take GLP-1 medications

GLP-1 medications are not appropriate for everyone. You should not start treatment if any of the following apply:

  • Personal or family history of medullary thyroid cancer (MTC).
  • Personal or family history of multiple endocrine neoplasia type 2 (MEN 2).
  • Current pregnancy, planned pregnancy, or breastfeeding — discontinue at least two months before a planned pregnancy.
  • Known hypersensitivity to semaglutide, tirzepatide, or any inactive ingredient in the product.
  • Prior history of pancreatitis (relative contraindication — discuss with your prescribing clinician).

This list summarizes the labeled contraindications and is not a substitute for medical evaluation. A qualified healthcare professional must review your history before any prescription is issued.

Frequently asked questions

Which is cheaper over 12 months — Hims & Hers or Zealthy?
Zealthy is cheaper over 12 months. Hims & Hers totals $2,938; Zealthy totals $2,874.
Do Hims & Hers and Zealthy offer FDA-approved medications?
Hims & Hers: Yes. Zealthy: Yes.
Can I switch from Hims & Hers to Zealthy?
Switching providers is typically straightforward — both programs are month-to-month and do not lock members into annual contracts. Keep in mind that changing medication or dose should involve your clinician, and that any unused medication already shipped is generally non-refundable.